SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 52,300
-800 (-1.51%)
Dec 10, 2025, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 4.1 trillion as of December 10, 2025. Its market cap has increased by 13.24% in one year.
Market Cap
4.10T
Enterprise Value
3.74T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
52,300.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 4.10T, a decrease of -68.30%. That is a compound annual growth rate of -21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 4.10T | 3.80% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |